ポイントオブケア分子診断の世界市場レポート 2025年

ポイントオブケア分子診断の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR15.0％で70億2,000万米ドルに成長します。予測期間の成長は、診断機器の小型化、がんや遺伝性疾患に対するPOC検査の拡大、多様な用途向けのカスタマイズされた分子診断、データ分析のためのaiと機械学習の統合、新たな感染症サーベイランスなどに起因すると考えられます。予測期間の主な動向には、ラボオンチップとマイクロ流体技術、デジタルヘルスとスマートフォンベースの診断、ポイントオブケアCOVID-19とパンデミックへの備え、AI主導の予測診断、crisprベースの分子検査が含まれます。

感染症や呼吸器疾患の著しい増加は、ポイントオブケア分子診断市場の成長を促進する主要因になると予測されます。呼吸器感染症の原因となる微生物は、ウイルス性であれ細菌性であれ、咳やくしゃみ、直接接触などさまざまな手段で感染します。これらの疾患の重症度は、吸入薬、経口薬、点滴治療、効果的な患者ケアのためのポイントオブケア分子診断など、さまざまな治療を必要とします。例えば、Office for National Statisticsによると、イングランドでは、35歳から69歳、12歳から24歳の学齢期における感染率が増加しており、感染症や呼吸器疾患への効果的なポイントオブケア分子診断への対応が急務であることが浮き彫りになっています。

心不全治療に対する意識の高まりは、ポイントオブケア（POC）分子診断市場の成長を促進します。心不全は、血液を効果的に送り出す心臓の能力に影響を与える疾患であり、POC分子診断が早期介入と患者の転帰改善のための迅速かつ正確な診断を提供することで、大きな利益を得ることができます。米国心臓協会の報告によると、心不全の診断数は増加しており、2030年までに46％増加し、心不全患者は800万人を超えると予測されています。インドでは、農村部でも都市部でも冠動脈疾患が急増しています。このような心不全治療に対する意識の高まりは、POC分子診断がこの医療領域で重要な役割を果たす可能性を強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のポイントオブケア分子診断PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のポイントオブケア分子診断市場：成長率分析
• 世界のポイントオブケア分子診断市場の実績：規模と成長, 2019-2024
• 世界のポイントオブケア分子診断市場の予測：規模と成長, 2024-2029, 2034F
• 世界のポイントオブケア分子診断総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のポイントオブケア分子診断市場：製品とサービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アッセイとキット
• 機器と分析装置
• ソフトウェアとサービス
• 世界のポイントオブケア分子診断市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 逆転写ポリメラーゼ連鎖反応（RT-PCR）
• インサイチューハイブリダイゼーション
• シーケンシング
• 世界のポイントオブケア分子診断市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 呼吸器疾患
• 院内感染（HAI）
• がん/腫瘍学
• 肝炎
• 血液学
• 世界のポイントオブケア分子診断市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分散型ラボ
• 病院
• ホームケア
• 介護付き生活ヘルスケア施設
• 世界のポイントオブケア分子診断市場：アッセイとキットのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 核酸増幅検査（NAAT）
• 迅速診断テスト
• 分子検出キット
• 試薬および消耗品
• 世界のポイントオブケア分子診断市場：機器および分析装置のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• PCRマシン
• マイクロ流体デバイス
• シーケンサー
• ポイントオブケア分析装置
• 世界のポイントオブケア分子診断市場：ソフトウェアとサービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• データ管理ソフトウェア
• クラウドベースのソリューション
• 技術サポートおよびメンテナンスサービス
• コンサルティングおよびトレーニングサービス

第7章 地域別・国別分析

• 世界のポイントオブケア分子診断市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のポイントオブケア分子診断市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ポイントオブケア分子診断市場：競合情勢
• ポイントオブケア分子診断市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Sysmex Corporation
• Illumina Inc.
• Myriad Genetics Inc.
• Siemens Healthcare GmbH
• Almac Group
• Biogenex Laboratories Inc.
• Cepheid Inc.
• Epic Sciences Inc.
• Foundation Medicine Inc.
• Genomic Health Inc.
• Grail Inc.
• Hologic Inc.
• HTG Molecular Diagnostics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ポイントオブケア分子診断市場2029：新たな機会を提供する国
• ポイントオブケア分子診断市場2029：新たな機会を提供するセグメント
• ポイントオブケア分子診断市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Point-of-care (POC) molecular diagnostics are tests designed to detect specific nucleic acids in clinical specimens, including feces, saliva, urine, blood, and tissue. These diagnostics rely on identifying targeted portions of microbial genetic material, specifically DNA or RNA. Widely utilized in the healthcare sector, POC molecular diagnostics are granted emergency usage authorization to diagnose various diseases. These diagnostics are instrumental in detecting disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS).

The primary products and services in point-of-care molecular diagnostics include assays and kits, instruments and analyzers, and software and services. Assays and kits are equipment used to carry out analyses, especially in studying disease pathways. They are commonly employed for rapid and accurate diagnosis and monitoring of various diseases. Technologies such as reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and sequencing are utilized in POC molecular diagnostics for diagnosing diseases like respiratory diseases, hospital-acquired infections (HAIs), cancer/oncology, hepatitis, and hematology. Point-of-care molecular diagnostics are employed in decentralized labs, hospitals, home care, and assisted living healthcare facilities.

The point-of-care molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care molecular diagnostics market statistics, including point-of-care molecular diagnostics industry global market size, regional shares, competitors with a point-of-care molecular diagnostics market share, detailed point-of-care molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care molecular diagnostics industry. This point-of-care molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care molecular diagnostics market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $4.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing demand for rapid disease diagnosis, growth in infectious disease outbreaks, expansion of telemedicine and remote testing, regulatory support for point-of-care diagnostics, need for personalized and precision medicine.

The point-of-care molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.02 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to miniaturization of diagnostic devices, expansion of poc testing for cancer and genetic diseases, customized molecular diagnostics for diverse applications, integration of ai and machine learning for data analysis, emerging infectious disease surveillance. Major trends in the forecast period include lab-on-a-chip and microfluidic technologies, digital health and smartphone-based diagnostics, point-of-care covid-19 and pandemic preparedness, ai-driven predictive diagnostics, crispr-based molecular testing.

The significant rise in the prevalence of infectious and respiratory diseases is anticipated to be a major driver for the growth of the point-of-care molecular diagnostics market. Microorganisms causing respiratory infections, whether viral or bacterial, can spread through various means, including coughing, sneezing, or direct contact. The severity of these diseases necessitates a range of treatments, including inhalers, oral medications, intravenous treatments, and point-of-care molecular diagnostics for effective patient care. For example, in England, according to the Office for National Statistics, the infection rate increased among individuals aged 35 to 69 and those in school years 12 to 24, highlighting the urgency for effective point-of-care molecular diagnostics to address infectious and respiratory diseases.

The increasing awareness regarding heart failure treatment is poised to propel the growth of the point-of-care (POC) molecular diagnostics market. Heart failure, a condition impacting the heart's ability to pump blood effectively, can benefit significantly from POC molecular diagnostics, offering swift and accurate diagnoses for early interventions and improved patient outcomes. The American Heart Association reports a rising number of heart failure diagnoses, projected to increase by 46% by 2030, exceeding 8 million people with heart failure. In India, coronary incidences have surged in both rural and urban populations. This growing awareness about heart failure treatment underscores the potential for POC molecular diagnostics to play a crucial role in this medical domain.

A key trend gaining traction in the point-of-care molecular diagnostics market is technological innovation. Major market players are dedicated to providing advanced solutions to strengthen their market positions. Companies are incorporating next-generation technologies such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, DNA microarrays, etc., on POC devices, accelerating analysis times and reducing costs. For instance, Sensible Diagnostics introduced a 10-minute point-of-care PCR system, showcasing technological advancements to provide rapid results.

Strategic partnerships are being embraced by major players in the point-of-care molecular diagnostics market to launch POC CRISPR-based tests. For instance, CrisprBits collaborated with MolBio Diagnostics to leverage biotechnology expertise and translation, manufacturing, and distribution capabilities for developing POC tests detecting pathogens and genetic markers.

In July 2024, Roche Holding AG, a Switzerland-based global healthcare company focused on developing medicines, treatments, and diagnostics, acquired LumiraDx Ltd. for an undisclosed amount. This acquisition is intended to enhance Roche Holding AG's diagnostics portfolio, improve access to decentralized healthcare solutions, and expand testing capabilities, especially in underserved regions. LumiraDx Ltd. is a UK-based diagnostic company that specializes in creating innovative point-of-care (POC) testing solutions.

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMerieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the point-of-care molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The point-of-care (POC) molecular diagnostics market includes revenues earned by AAT, antigen, or antibody tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care Molecular Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point-of-care molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point-of-care molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Assays And Kits; Instruments And Analyzers; Software And Services
• 2) By Technology: Reverse Transcription - Polymerase Chain Reaction (RT-PCR); In Situ Hybridization; Sequencing
• 3) By Application: Respiratory Diseases; Hospital Acquired Infections (HAIs); Cancer/Oncology; Hepatitis; Hematology
• 4) By End-User: Decentralized Labs; Hospitals; Home Care; Assisted Living Healthcare Facilities
• Subsegments:
• 1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs); Rapid Diagnostic Tests; Molecular Detection Kits; Reagents And Consumables
• 2) By Instruments And Analyzers: PCR Machines; Microfluidic Devices; Sequencers; Point-of-Care Analyzers
• 3) By Software And Services: Data Management Software; Cloud-Based Solutions; Technical Support And Maintenance Services; Consultation And Training Services
• Companies Mentioned: Abbott Laboratories; F Hoffmann-La Roche Ltd.; BioMerieux SA; Danaher Corporation; Quidel Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point-Of-Care Molecular Diagnostics Market Characteristics

3. Point-Of-Care Molecular Diagnostics Market Trends And Strategies

4. Point-Of-Care Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Point-Of-Care Molecular Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Point-Of-Care Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Point-Of-Care Molecular Diagnostics Market Growth Rate Analysis
• 5.4. Global Point-Of-Care Molecular Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Point-Of-Care Molecular Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Point-Of-Care Molecular Diagnostics Total Addressable Market (TAM)

6. Point-Of-Care Molecular Diagnostics Market Segmentation

• 6.1. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Assays And Kits
• Instruments And Analyzers
• Software And Services
• 6.2. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reverse Transcription - Polymerase Chain Reaction (RT-PCR)
• In Situ Hybridization
• Sequencing
• 6.3. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Respiratory Diseases
• Hospital Acquired Infections (HAIs)
• Cancer/Oncology
• Hepatitis
• Hematology
• 6.4. Global Point-Of-Care Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Decentralized Labs
• Hospitals
• Home Care
• Assisted Living Healthcare Facilities
• 6.5. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Assays And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Amplification Tests (NAATs)
• Rapid Diagnostic Tests
• Molecular Detection Kits
• Reagents And Consumables
• 6.6. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Instruments And Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Machines
• Microfluidic Devices
• Sequencers
• Point-of-Care Analyzers
• 6.7. Global Point-Of-Care Molecular Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Management Software
• Cloud-Based Solutions
• Technical Support And Maintenance Services
• Consultation And Training Services

7. Point-Of-Care Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Point-Of-Care Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Point-Of-Care Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point-Of-Care Molecular Diagnostics Market

• 8.1. Asia-Pacific Point-Of-Care Molecular Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point-Of-Care Molecular Diagnostics Market

• 9.1. China Point-Of-Care Molecular Diagnostics Market Overview
• 9.2. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point-Of-Care Molecular Diagnostics Market

• 10.1. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point-Of-Care Molecular Diagnostics Market

• 11.1. Japan Point-Of-Care Molecular Diagnostics Market Overview
• 11.2. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point-Of-Care Molecular Diagnostics Market

• 12.1. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point-Of-Care Molecular Diagnostics Market

• 13.1. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point-Of-Care Molecular Diagnostics Market

• 14.1. South Korea Point-Of-Care Molecular Diagnostics Market Overview
• 14.2. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point-Of-Care Molecular Diagnostics Market

• 15.1. Western Europe Point-Of-Care Molecular Diagnostics Market Overview
• 15.2. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point-Of-Care Molecular Diagnostics Market

• 16.1. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point-Of-Care Molecular Diagnostics Market

• 17.1. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point-Of-Care Molecular Diagnostics Market

• 18.1. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point-Of-Care Molecular Diagnostics Market

• 19.1. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point-Of-Care Molecular Diagnostics Market

• 20.1. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point-Of-Care Molecular Diagnostics Market

• 21.1. Eastern Europe Point-Of-Care Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point-Of-Care Molecular Diagnostics Market

• 22.1. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point-Of-Care Molecular Diagnostics Market

• 23.1. North America Point-Of-Care Molecular Diagnostics Market Overview
• 23.2. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point-Of-Care Molecular Diagnostics Market

• 24.1. USA Point-Of-Care Molecular Diagnostics Market Overview
• 24.2. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point-Of-Care Molecular Diagnostics Market

• 25.1. Canada Point-Of-Care Molecular Diagnostics Market Overview
• 25.2. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point-Of-Care Molecular Diagnostics Market

• 26.1. South America Point-Of-Care Molecular Diagnostics Market Overview
• 26.2. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point-Of-Care Molecular Diagnostics Market

• 27.1. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point-Of-Care Molecular Diagnostics Market

• 28.1. Middle East Point-Of-Care Molecular Diagnostics Market Overview
• 28.2. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point-Of-Care Molecular Diagnostics Market

• 29.1. Africa Point-Of-Care Molecular Diagnostics Market Overview
• 29.2. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Point-Of-Care Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point-Of-Care Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Point-Of-Care Molecular Diagnostics Market Competitive Landscape
• 30.2. Point-Of-Care Molecular Diagnostics Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. BioMerieux SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quidel Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Point-Of-Care Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. BioMerieux SA
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Sysmex Corporation
• 31.4. Illumina Inc.
• 31.5. Myriad Genetics Inc.
• 31.6. Siemens Healthcare GmbH
• 31.7. Almac Group
• 31.8. Biogenex Laboratories Inc.
• 31.9. Cepheid Inc.
• 31.10. Epic Sciences Inc.
• 31.11. Foundation Medicine Inc.
• 31.12. Genomic Health Inc.
• 31.13. Grail Inc.
• 31.14. Hologic Inc.
• 31.15. HTG Molecular Diagnostics Inc.

32. Global Point-Of-Care Molecular Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point-Of-Care Molecular Diagnostics Market

34. Recent Developments In The Point-Of-Care Molecular Diagnostics Market

35. Point-Of-Care Molecular Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Point-Of-Care Molecular Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Point-Of-Care Molecular Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Point-Of-Care Molecular Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer